相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bacterial and Fungal Keratitis: A Retrospective Analysis at a University Hospital in Switzerland
Alexandra Bograd et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2019)
Evidence for biofilms in onychomycosis
Aditya K. Gupta et al.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA (2019)
South Indian Isolates of the Fusarium solani Species Complex From Clinical and Environmental Samples: Identification, Antifungal Susceptibilities, and Virulence
Monika Homa et al.
FRONTIERS IN MICROBIOLOGY (2018)
Fusarium Keratitis in Germany
Grit Walther et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Fusarium solani species complex: ubiquitous pathogens of agricultural importance
Jeffrey J. Coleman
MOLECULAR PLANT PATHOLOGY (2016)
Comparison Between Polymicrobial and Fungal Keratitis: Clinical Features, Risk Factors, and Outcome
Merle Fernandes et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Mycotic keratitis: epidemiology, diagnosis and management
P. A. Thomas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry
E. De Carolis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2
Ahmad B. Tarabishy et al.
JOURNAL OF IMMUNOLOGY (2008)
Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution
Douglas C. Chang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts
F. Sabatelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
RE Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Human fusariosis
MC Dignani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Immunosuppression affects the severity of experimental Fusarium solani keratitis
TG Wu et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole
VH Bigley et al.
BONE MARROW TRANSPLANTATION (2004)
Successsful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient
S Consigny et al.
CLINICAL INFECTIOUS DISEASES (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
In vitro activities of investigational triazoles against Fusarium species:: Effects of inoculum size and incubation time on broth microdilution susceptibility test results
NI Paphitou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis
M Ortoneda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Aspects of fungal pathogenesis in humans
JAH van Burik et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)
HPC viability measurement: trypan blue versus acridine orange and propidium iodide
K Mascotti et al.
TRANSFUSION (2000)
分享论文
